Canada markets closed

BP p.l.c. (BPAQF)

OTC Markets OTCPK - OTC Markets OTCPK Delayed Price. Currency in USD
Add to watchlist
5.900.00 (0.00%)
At close: 10:13AM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close5.90
Bid5.75 x 40000
Ask6.00 x 396000
Day's Range5.90 - 5.90
52 Week Range5.30 - 6.85
Avg. Volume10,006
Market Cap98.151B
Beta (5Y Monthly)0.52
PE Ratio (TTM)10.93
EPS (TTM)0.54
Earnings DateJul 30, 2024
Forward Dividend & Yield0.29 (4.85%)
Ex-Dividend DateMay 16, 2024
1y Target EstN/A
  • Zacks

    Top Analyst Reports for Abbott, BP & Gilead

    Today's Research Daily features new research reports on 16 major stocks, including Abbott Laboratories (ABT), BP p.l.c. (BP) and Gilead Sciences, Inc. (GILD), as well as two micro-cap stocks Smith-Midland Corporation (SMID) and Crimson Wine Group, Ltd. (CWGL).

  • Reuters

    BP plans foray into 2G ethanol, sustainable jet fuel with Brazil base

    BP Plc will evaluate expanding and diversifying its biofuel operation in Brazil, looking at new products such as second-generation ethanol and sustainable aviation fuel after buying out Bunge from their joint venture BP Bunge Bioenergia. The company said in written comments to Reuters that it wants to use the venture's massive biofuel base in Brazil - an industrial complex with 11 plants in five states processing sugarcane - to develop key projects to support the broader BP view for bioenergy. The Brazil complex "is a scalable bioenergy platform with cost advantages," it said.

  • Zacks

    BP to Acquire Full Control of Biofuels Joint Venture for $1.4B

    BP has agreed to buy Bunge's 50% interest in their joint venture (JV), BP Bunge Bioenergia. The $1.4 billion deal will give BP full ownership of the JV, enabling streamlined operations and a refined focus on profitable biofuel developments.